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Communication between neuronal and glial cells is important for neural plasticity. P2X receptors are ATP-gated cation channels
widely expressed in the brain where they mediate action of extracellular ATP released by neurons and/or glia. Recent data show that
postsynaptic P2X receptors underlie slow neuromodulatory actions rather than fast synaptic transmission at brain synapses. Here,
we review these findings with a particular focus on the release of ATP by astrocytes and the diversity of postsynaptic P2X-mediated
modulation of synaptic strength and plasticity in the CNS.
1. Introduction
Adenosine 5′-triphosphate (ATP) is arguably one of the most
abundant molecules in living cells serving as universal energy
“currency.” So, it is of no surprise that ATP is also widely uti-
lized as an extracellular signaling molecule [1]. Extracellular
ATP acts as an excitatory neurotransmitter in the brain, spi-
nal cord, and peripheral nerve terminals [2–4]. Furthermore,
ATP can act as a “gliotransmitter” transferring signals within
glial networks or between neurons and glial cells [2–5]. The
metabolic breakdown of extracellular ATP by ectonucleoti-
dases is also a source of other nucleotides and adenosine.
Adenosine acts as neurotransmitter and neuromodulator in
the central nervous system (CNS) through activation of
adenosine G protein-coupled receptors that are widely
expressed in glia and neurons at both pre- and postsynaptic
levels. Adenosine plays important physiological roles in the
brain in health and diseases detailed in recent review articles
[6–10]. The action of ATP as neuro- or gliotransmitter is
mediated by a broad family of purinergic receptors expressed
in neurons and glia. P2 receptors are classified into several
subtypes of ligand-gated ion channels (P2X1–P2X7 subunits)
and eight distinct G protein-coupled receptors (P2Y) which
are both characterized by a variety of distinct properties
and a broad range of ATP sensitivities ranging from nano-
molar (P2Y receptor) to tenth micromolar (P2X) or millimo-
lar for P2X7 [1, 11–14]. The seven P2X subunits share a
unique and simple architecture with two hydrophobic
membrane-spanning domains separated by a large extracel-
lular domain and two intracellular termini. They assemble
as homo- or heterotrimers to form diverse nonselective cat-
ion channels with distinct kinetics and pharmacological
properties. All P2X subunits are expressed in neural cells in
a heterogeneous manner through the brain regions, cell
types, and subcellular compartments [15–17]. Consequently,
the subunit composition of P2X receptors in most of central
neurons is far from being characterized. Neuronal P2 recep-
tors are expressed at pre- and postsynaptic loci [18]. Presyn-
aptic P2 receptors play a critical role in the regulation of
neurotransmitter release [10, 11] by contributing to the intra-
cellular Ca2+ signaling [11, 13] by virtue of the high Ca2+ per-
meability (P2X) and ability to stimulate IP3-dependent Ca2+
release from endoplasmic reticulum (P2Y). These properties
can underlie also an important role for postsynaptic P2X
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receptors in the modulation of synaptic activities highlighted
relatively recently [12]. In this review, the recent knowledge
on the role of postsynaptic P2X receptors focused on glia-
neuron interactions is summarized.
2. Release of ATP by Glial Cells
An ability of astrocytes to release ATP has been suggested by
studies showing the participation of ATP in the propagation
of glial Ca2+ waves and the significant contribution of ATP
and adenosine to the astroglia-driven modulation of neuro-
nal activity and sleep homeostasis [3, 19–21]. A variety of
molecular mechanisms of ATP release from astrocytes have
been suggested, including exocytosis and concentration
gradient-driven diffusion through large conductance chan-
nels such as gap junction hemichannels, anion channels,
and dilated P2X7 receptors [3, 5, 21].
In addition to astrocytes, a significant amount of extracel-
lular ATP can be released from microglia, in particular dur-
ing neuroinflammation [2, 22–24]. Microglia-derived ATP
has been reported to activate P2X receptors in the hippocam-
pal and spinal cord neurons [22–24].
From the early days of research into glial-neuron interac-
tion, a concept of fast vesicular release of chemical transmit-
ters, including ATP, from astrocytes attracted a big attention
and was embedded in the popular concept of tripartite syn-
apse [25] which had implied the equal importance of astro-
cytes for synaptic physiology. Indeed, there is a large body
of evidence that the release of ATP from astrocytes may share
common mechanisms of vesicular neurotransmitter release
such as a dependence on the proton gradient, vesicular
transporters, and SNARE proteins and intracellular Ca2+
elevation [20, 26–29]. There are also accumulating reports
of physiological roles for SNARE-dependent glial exocyto-
sis [19, 21, 28]. In particular, exocytosis of ATP followed
by its conversion to adenosine has been implicated into
the regulation of LTP in the the hippocampus and sleep
homeostasis in the hypothalamus [21]. The key element
of latter works was the development of dnSNARE trans-
genic mice with inducible inhibition of exocytosis selec-
tively in astrocytes [21].
Yet, the physiological relevance of vesicular release of
gliotransmitters is intensively debated [26, 27]. This debate
has been fuelled by an argument that the bulk of evidence
supporting the SNARE-dependent release of gliotransmitters
was obtained mostly in cell cultures where functional proper-
ties of astrocytes can be dramatically altered by various arte-
facts [27]. Until recently, there were mainly circumstantial
evidence of Ca2+-dependent release of ATP from glial cells
in brain slice based on the inhibitory action of P2X receptor
antagonists on glia-driven modulation of synaptic transmis-
sion and plasticity [19, 30, 31]. A definitive evidence of vesic-
ular release of ATP from astrocytes in situ, based on several
experimental approaches, has been demonstrated only
recently [28, 32, 33]. These works have demonstrated that
quantal release of ATP from cortical astrocytes can be trig-
gered by the cytosolic Ca2+ elevation, attainable in physiolog-
ical conditions [28, 32, 33] and can be inhibited by the
intracellular perfusion of astrocytes with light chain of
tetanus toxin or inhibitors of vesicular nucleotide trans-
porters. The release of ATP was impaired in the transgenic
mice expressing dnSNARE protein selectively in astroglial
cells [28, 33]. One should emphasize that this effect could
hardly be attributed to the allegedly “leaky” expression [34]
of dnSNARE transgene in neurons since there was no deficit
in the GABAergic and glutamatergic synaptic transmission
[28, 33]. Also, the lack of neuronal expression of dnSNARE
has been recently verified by other labs [35, 36]. The release
of ATP from cortical astrocytes can occur, most likely, from
synaptic-like microvesicles and lysosomes [28]. Importantly,
these works also provide a direct demonstration of capability
of astrocyte-derived ATP to activated P2X receptors in neu-
rons, most likely located at the extrasynaptic sites [28].
The above works also reported a presence of nonvesicular
release of ATP from astrocytes which is in agreement with
previous data suggesting a participation of connexin hemi-
channels and/or volume-sensitive channels in glia release of
ATP [3, 30, 37]. However, the contribution of nonvesicular
mechanisms into the release of ATP from cortical astrocytes
at physiological conditions was not large and the dominant
role was played by vesicular mechanisms [28]. The major
contribution of vesicular mechanisms into the release of
ATP has also been reported for brainstem astrocytes in vivo
[19]. The notion of the coexistence of vesicular and nonvesi-
cular mechanisms of ATP release and the dominant role of
vesicular pathway are in line with previous results obtained
in the spinal cord astrocytes [37]. The latter work showed
that fast initial astroglial exocytosis of ATP triggered a
robust, but slow, secondary release of ATP through the pan-
nexin and connexin hemichannels [37]. One should also note
that the data supporting a major role for nonvesicular mech-
anisms of ATP release in the brain were often reported by
works aimed to study the excitotoxicity of ATP after ischemic
tissue damage or during neurological disorders [2, 3, 38].
Thus, a consensus view on the mechanism of glial ATP
release might be a participation of both exocytosis- and
channel-dependent pathways, with the relative contributions
former being smaller at physiological conditions but increas-
ing in the context of brain pathologies. It is also feasible that
relative contribution of vesicular/nonvesicular mechanisms
into gliotransmitter release can be region-specific as many
other functions of astrocytes. There is also evidence that the
release of ATP from astrocytes can undergo significant age-
related changes [39]. Whatever is a mechanism, the release
of ATP represents a powerful pathway of glia-neuron inter-
action which has already been implicated into a variety of
physiological functions, including breathing control [19],
slow neuromodulation [30, 31, 40], and modulation of sleep
homeostasis [21] (after conversion into adenosine). Yet, the
most intriguing and frequently overlooked role for glia-
derived ATP is the regulation of synaptic strength, which will
be discussed in detail below.
3. Neuromodulatory Action of Postsynaptic P2X
Receptors in the CNS
ATP showed to be released by exocytosis from the nerve ter-
minal and acts as a fast synaptic neurotransmitter in the
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nervous system though activation of postsynaptic P2X
receptors [41–46]. If there is robust evidence of fast transmis-
sion mediated by ATP and P2X receptors in the peripheral
nervous system such as sympathetic neurons, at neuromus-
cular junction or in myenteric nervous system, such a form
of ATP-mediated fast synaptic transmission is more rarely
observed in the CNS (see for review [11]). Following the
first evidence for fast excitatory ATP postsynaptic currents
recorded in the medial habenula [41, 42], fast ATP synap-
tic transmission mediated by activation of postsynaptic
P2X receptors was also reported in several other brain
regions such as the locus coeruleus, the hippocampus, the
hypothalamus, and the cortex as well as in the spinal cord
[5, 43, 44, 46, 47]. However, evoked P2X-mediated post-
synaptic currents required generally strong electrical stimu-
lation of afferent fibers and are of weak amplitude [32, 45].
To date, there is no example of action potential firing
induced by synaptic release of ATP and activation of P2X
receptors in the CNS. In addition, rare spontaneous or
miniature P2X-mediated excitatory postsynaptic currents
were recorded at central synapses conveying the idea that
ATP and postsynaptic P2X receptors do not act primarily
as fast excitatory neurotransmitter at brain synapses [12]
and, thus, despite the detection of several P2X subunits
at the postsynaptic sites of glutamatergic synapses [15].
Several studies suggested that postsynaptic P2X receptors
modulate fast synaptic responses mediated by other fast
neurotransmitters (see for review [12, 48]). Recent works
have showed that ATP released by glial cells and/or by
the presynaptic terminals acting on postsynaptic P2X
receptors have various and profound effects on synaptic effi-
cacy and plasticity at both the excitatory and inhibitory syn-
apses in several brain areas [28, 30–32, 40, 49]. There is also
evidence of abundant expression of various P2X receptor
subtypes at presynaptic loci [15] and presynaptic effects of
P2X and P2Y receptors on the release of glutamate, GABA,
and other neurotransmitters in different brain regions and
the spinal cord [1, 10, 11, 15, 50–52]. These results gave rise
to the hypothesis that the main role for ATP and P2X-
mediated signaling in CNS is neuromodulation rather than
fast neurotransmission [12, 52].
Although the presynaptic action of the P2 receptors on
the release of various neurotransmitters have been studied
for last two decades (see for review [10, 11]), the notion of
physiological importance of the postsynaptic purinergic
modulation has been highlighted relatively recently [12].
Several arguments were already in favor of the modulatory
action of ATP released from nerve terminals and postsyn-
aptic P2X receptors. The first is that no brain synapses to
date used solely ATP as excitatory neurotransmitter but
ATP is frequently coreleased from the same terminals with
other transmitters such as glutamate or γ-amino-butyric
acid (GABA) [32, 43, 44, 47, 53]. Consistent with this
idea, electron microscopy indicated that P2X2, P2X4, and
P2X6, the predominant fast purinoceptors expressed in
the majority of brain neurons, are postsynaptically located
and mainly localized at the edge of the postsynaptic den-
sity synapses in the peri- and extrasynaptic space [16] at
least at the basal levels of neuronal activity. In contrast,
AMPAR or GABAAR which mediate, respectively, the
rapid excitatory and inhibitory synaptic transmission are
concentrated at the synapses facing the site of neurotrans-
mitter release from the presynaptic terminal [54, 55].
Single-molecule imaging methods allow now the visualiza-
tion of the lateral movement of receptors in the postsynap-
tic membrane. They have revealed that AMPAR and
GABAAR permanently exchange between synaptic and
extrasynaptic locations and alternate between periods of lat-
eral mobility at extrasynaptic sites, and periods of immobil-
ity at synapses [56]. In contrast, single particle tracking of
P2X2 or P2X4 receptors has shown that they are all very
mobile and that their diffusion can be facilitated upon their
activation by ATP [57]. In transfected neurons, P2X2
receptors moved within the membrane of dendrites and at
extrasynaptic sites. In addition, these data showed that
P2X2 receptors rarely enter into the glutamatergic synapse
suggesting that P2X receptors are excluded from the post-
synaptic density synapses reinforcing the electron micros-
copy data [58].
The lack of detectable P2X-mediated synaptic current is
also consistent with the fact that the surface trafficking of
P2X4 receptors is highly regulated. P2X4 receptors are con-
stitutively internalized by dynamin-dependent endocytosis
[59, 60] through interaction between the adaptor protein
AP2 and a novel noncanonical endocytosis motif present
exclusively in P2X4 subtype [59, 61, 62]. As a result,
P2X4-containing receptors are retained predominantly in
intracellular pools, limiting their putative implication in
ATP signaling originating from either neuron or glia in nor-
mal conditions. However, intracellular pools of P2X4 recep-
tors that are resistant to lysosomal degradation can be
rapidly trafficked to the surface membrane increasing the
surface number of functional P2X4 receptors [63]. Apart
from P2X2, P2X4, and P2X6 subtypes, the presence of other
subtypes, such as P2X1 or P2X3, in the central synapses has
been suggested based both of the electrophysiological/phar-
macological data and colocalisation with synaptic markers
[15, 44, 45]; the presence of heteromeric P2X1/4 and P2X2/
3 also cannot be excluded. Since P2X1 and P2X3 receptors
are prone to the fast desensitisation, internalisation, and lat-
eral mobility [1, 64], the subtype composition and overall
density of P2X receptors at the given synapse may undergo
substantial variations, very likely in the activity-dependent
manner. Interestingly, a recent study of P2X receptor-
mediated signaling in individual cortical synapses sug-
gested that ATP released either from synaptic terminals
or from astrocytes can upregulate the trafficking of post-
synaptic P2X receptors via different Ca2+-dependent mech-
anisms [32].
This is likely to be important because an upregulation of
surface P2X receptors (in particular P2X4 subtype) was
observed in various pathophysiological contexts such as
ischemia, chronic pain [23], or neurodegenerative diseases
such as amyotrophic lateral sclerosis (ALS) or Alzheimer’s
disease (AD) [38, 65–67]. So, excessive release of ATP from
various sources, including astrocytes and microglia, can con-
fer a particular importance of the neuromodulatory action of
P2X receptors in pathological conditions.
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4. Modulation of Glutamatergic Excitatory
Synapse by P2X Receptors
NMDAR and AMPAR have critical roles in excitatory synap-
tic transmission and plasticity in the CNS [68]. Synaptic
strength is thought to be determined in part through the
activity-dependent insertion and removal of synaptic
AMPAR which lead to long-term potentiation (LTP) and
long-term depression (LTD), that are widely recognized to
underlie cognitive functions such as learning and memory
[68–70]. AMPARs are tetrameric complexes composed of
GluA1-A4 subunits [71]. The lateral diffusion and the intra-
cellular trafficking (endocytosis/exocytosis) are regulated by
subunit-specific AMPAR-interacting proteins as well as by
various posttranslational modifications on their intracellular
domains [72, 73]. The bidirectional fast changes in the num-
ber of synaptic AMPARs are mainly triggered by activation
of NMDAR or mGluR during synaptic plasticity.
4.1. Direct Modulation of AMPAR and Glutamatergic
Synapse Efficacy by Glial ATP. Two noteworthy studies
showed that direct activation of postsynaptic P2X receptors
by endogenous ATP plays also a crucial role in glutamatergic
synaptic transmission [30, 40]. These two works provide
strong evidence that postsynaptic P2X receptors activated
by ATP released from astrocytes resulted in enduring
changes of glutamatergic synaptic efficacy in distinct brain
areas. The first work showed in the paraventricular nucleus
of the hypothalamus, a long lasting increase in the amplitude
of AMPAR-mediated mEPSC in response to brief application
of noradrenaline (NA) that requires the release of ATP from
glial cells [30]. It has been demonstrated that NA acted on
astrocytic α1-adrenoceptors and triggered the release of
ATP by astrocytes. In addition, the pharmacological block-
ade by fluoroacetate (FAC) of the glial metabolism or physi-
ological decrease by dehydration of the astrocytic coverage of
the synapses onto magnocellular neurons in the hypotha-
lamic neurosecretory system suppressed the increase in syn-
aptic strength. The increase of AMPAR-mediated mEPSC is
mediated by P2X receptors’ activation and calcium influx
and phosphatidylinositol 3-kinase (PI3K) resulting likely in
the insertion of new AMPAR at the synapse. The effect of
NA on the AMPAR-mediated mEPSCs was mimicked by
ATP or benzoyl ATP, a more stable analogue of ATP, and
blocked in the presence of brilliant blue G (BBG) in favor
of the involvement of P2X7 receptors [30]. P2X7 subunit is
possibly expressed in the magnocellular neurons of the hypo-
thalamus with several other subunits [17]; but P2X7 is rarely
expressed in neurons suggesting that this mechanism could
be restricted to specific neuronal populations. It was showed
later that P2X2 and P2X5 formed a heteromeric P2X receptor
with an apparent affinity for ATP similar to P2X2 (~10μM)
and P2X7-like functional properties [74]. This suggests that
such form of plasticity could be mediated by more classical
neuronal P2X receptors and consequently more broadly
expressed in the brain (Figure 1).
The second work showed that activation of postsynaptic
P2X (likely P2X2) receptors by NA-dependent glial release
of endogenous ATP changed the glutamatergic synapses
efficacy in the hippocampus but in an opposite way [40]. Brief
application of ATP or NA-induced glial ATP release caused an
enduring and slow decrease of AMPAR-mediated mEPSCs in
hippocampal cultures. The effects of both ATP and NA were
blocked by PPADS, a P2X antagonist, and by FAC that
impairs astrocyte function. The same observation was repro-
duced on hippocampal brain slices where ATP and NA
caused a depression of field excitatory postsynaptic poten-
tials (fEPSPs) recorded in CA1 region that was also blocked
by PPADS or FAC. By complementary approaches, includ-
ing recordings and biochemistry from heterologous Xenopus
oocytes expressing mammalian P2X2 or P2X4 with AMPAR,
and high-resolution imaging from hippocampal neurons,
Pougnet and colleagues demonstrated that activation of
P2X2 or P2X4 receptors and calcium influx though the open-
ing of P2X channels triggered dynamin-dependent internali-
zation of GluA1 or GluA1/A2 AMPARs leading to reduced
surface AMPARs in dendrites and at synapses [40].
Although no fast ATP synaptic transmission was
detected in both brain structures, these studies showed that
ATP released by astrocytes increased the efficacy of gluta-
matergic synaptic transmission in paraventricular nucleus
and depressed synaptic efficacy in the CA1 region of the hip-
pocampus [30, 40]. This raised the possibility that astrocyte-
derived ATP and P2X receptors may bidirectionally change
the glutamatergic synapse efficacy in the brain.
Gordon and colleagues have also established that the
ATP signaling mechanism is engaged during an afferent
activity [31]. The activity-dependent release of NA or gluta-
mate by nerve terminals activates astrocytic mGluR or adre-
noceptors (Figure 1). The subsequent increase of intracellular
calcium in astrocyte leads to the release of ATP by astrocytes
and consequently activation of postsynaptic P2X receptors of
a large group of synapses covered by the astrocyte. Astrocytic
activation may spread within astrocytes resulting in multipli-
cative scaling of all synapses in MCNs. Thus, although not
contributing to the synaptic transmission, astrocyte-derived
ATP signaling is likely exerting strong neuromodulation dur-
ing physiological neuronal activation [31]. In addition, recent
studies [75, 76] showed that startle and arousal responses
in vivo are followed by NA-induced Ca2+ signaling in cortical
astrocytes raising also the possibility that P2X receptors may
contribute to the regulation of these behaviours [29].
The P2X-induced bidirectional changes in the efficacy of
glutamatergic transmission induce insertion and removal of
AMPAR at the synapses [30, 40]. P2X-mediated insertion
of AMPAR in MCNs is linked to PIK3 kinase [30] that is also
crucial for NMDA-dependent AMPAR insertion and LTP
[69] suggesting that P2X receptors may serve as a “surrogate”
for NMDAR [30]. In the hippocampus, P2X- and NMDA-
induced depression in the CA1 region were additive, suggest-
ing that both receptors are involved in distinct mechanisms
leading to the removal of AMPAR from the synapses [40].
This assumption was confirmed recently by a work showing
that P2X-mediated internalization of AMPAR is associated
to the phosphorylation level of two calcium/calmodulin-
dependent protein kinase II (CaMKII) phosphorylation sites
S567 and S831 located in the cytoplasmic Loop1 and C-
terminal tail of GluA1 subunits [49]. This work revealed also
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that P2X-mediated AMPAR inhibition is dependent on the
subunit composition of AMPAR. GluA1 or GluA1/A2 are
regulated by P2X activation while GluA3 homomers are
insensitive and their presence in heteromers alters P2X-
mediated inhibition. In addition, P2X-mediated depression
in CA1 P2X-induced depression in hippocampal slices pro-
duces a dephosphorylation of the GluA1 subunit at S567,
contrary to NMDAR-mediated LTD [49] (Figure 1).
Opposite effects of P2X-mediated changes of glutamater-
gic synapses’ efficacy were both triggered by the Ca2 influx
through the opening of P2X channels that activate distinct
intracellular pathways regulating AMPAR trafficking. Does
postsynaptic P2X receptors may bidirectionally change the
efficacy of a synapse depending on astrocytic release of
ATP, the dynamic of the Ca2+ influx though P2X receptors,
or the nature of AMPAR? Such possibility will be of interest
but requires additional studies since opposite effects were
observed in distinct neuronal population recruiting very
likely distinct P2X receptors.
4.2. Modulation of NMDAR-Dependent Plasticity. The
NMDAR-dependent LTP in hippocampal CA1 neurons
was shown to be modulated by P2X manipulation. Pharma-
cological blockade of P2X facilitated the induction of
NMDA-dependent LTP [46, 77] at lower frequencies of
action potential firing in Schaffer collateral axons suggesting
that P2X receptor activation reduced NMDA-dependent
LTP at low frequency stimulation [46, 77]. In contrast, a
study using P2X4 knockout mice revealed that LTP in CA1
neurons was slightly reduced compared to that in wild-type
mice [78]. In addition, ivermectin, a positive modulator of
P2X4 function or trafficking [79, 80], enhanced LTP in the
wild-type but not in P2X4 knock-out mice indicating a facil-
itatory action of P2X4 for hippocampal LTP [78]. No change
of the fast excitatory synaptic transmission between P2X4
knockout and wild-type mice confirmed the absence of con-
tribution of P2X4 in synaptic transmission, and the results
suggested that P2X4 receptors regulated NR2B content
within synaptic NMDAR [81].
Although controversial, altogether, these data argue in
favor of the neuromodulatory action of ATP signaling rather
than in fast synaptic transmission but also indicate that func-
tion of P2X receptors on NMDAR-dependent plasticity was
far to be understood. Recently, a study dissected the role of
synaptic and glial release of ATP in individual cortical synap-
ses [32]. This work provided the direct evidence that ATP
released from the individual excitatory synapses and/or glial
cells can activate P2X receptors in the neocortical neurons.
Moreover, the release of ATP from glial astrocytes turned
out to trigger a recruitment of P2X receptors into synapses
via Ca2+-dependent mechanism. Dependence of P2X recruit-
ment to synapses on glial activity may explain why, despite
evidence of widespread expression of P2X receptors in cen-
tral neurons, the purinergic components of fast EPSCs are
rarely observed and often require stronger stimulation to
evoke [12, 45].
So, glial and neuronal release of ATP can converge to
activation of postsynaptic P2X which, in turn, can cause
CAMKIICa
2+
Ca2+
Ca2+
GlutamateATP
NA NA
ATP
IP3
IP3
Ca2+
IP3
ATP
PKC
GABAATP
ATP
Ca2+
Ca2+
GlutamateATP
PI3K
Decrease of synaptic ecacy Increase of synaptic ecacy
PostsynapsePostsynapse
PresynapsePresynapse Presynapse
Astrocyte
process
Astrocyte
process
Postsynapse
mGLUR Adrenoceptor P2X receptors AMPAR NMDAR GABAAR
Excitatory synapse Inhibitory synapse
PPases
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a significant decrease in the synaptic currents mediated
by NMDAR (Figure 1). This effect was underlined by
the Ca2+-dependent dephosphorylation and interactions
between NMDARs and calcineurin within PSD-95 protein
complex [32, 82]. P2X-mediated downregulation of NMDA
receptors was inhibited in the mutant mice, lacking PSD-
95/Dlg4 domain (PSD-95 mutants) and the P2X4 knock-
out mice [32]. As one might expect, the downregulation
of NMDAR-mediated synaptic signaling had a strong
impact on long-term synaptic plasticity. Impairment of
purinergic modulation of NMDAR in the PSD-95 mutant
mice led to substantial upregulation of the long-term syn-
aptic plasticity in the neocortex which is manifested in the
decrease in the threshold of LTP induction and increase in
the net magnitude of LTP. These results are in line with the
previous observation of facilitation of LTP induction in
CA1 neurons after the inhibition of P2X receptors [46] and
previously reported increase in the extent of LTP in PSD-95
mutant mice [82]. One should note that purinergic downreg-
ulation of NMDARs was not mediated solely by P2X4;
contribution of other P2X subtypes was suggested by
pharmacological data [32, 46]. The P2Y receptors could
bring some, albeit moderate, contribution in the downregula-
tion of NMDARs since this effect was significantly reduced
after the removal of extracellular Ca2+ and could be
mimicked to a large extent by application α,β-meATP—a
selective P2X agonist [32, 43].
Interestingly, attenuation of purinergic modulation of
NMDARs in P2X4 KO mice also shifted the threshold
of LTP induction towards weaker stimuli but reduced
the net LTP amplitude. In general, such reduction of
the LTP amplitude in the neocortex agrees with previ-
ously reported decrease of LTP magnitude in the CA1
neurons of P2X4 KO mice [78]. The diversity of effects
exerted by P2X receptors on the LTP suggests an
involvement, in addition to inactivation of NMDARs,
another molecular cascades such as the abovementioned
bidirectional modulation of activity and trafficking of
AMPARs and the downregulation of GABA receptors
(see below).
Combined, these findings suggest an important role for
the interaction between postsynaptic P2X and NMDARs in
the regulation of synaptic strength. Coupling of NMDA
receptors to PSD-95 and multiprotein complex is essential
for the bidirectional modulation of synaptic strength and,
therefore, for proper function of synaptic networks underly-
ing learning and memory [82]. It has been shown previously
that overenhancement of LTP in the PSD-95 KO mutants is
accompanied by severe impairment of different forms of
learning [82, 83]. It becomes evident now that this important
pathway of control of NMDA receptor activity can be
exploited by postsynaptic P2X receptors activated by glia-
derived ATP. Such “premoderation” of plasticity of excit-
atory synapses can help to avoid “unwanted” or “excessive”
LTP, that is, reduce number of errors. This mechanism can
also increase a dynamic range of potentiation by presetting
the lower baseline level of the synaptic activity. The P2X-
mediated endocytosis of AMPAR [12, 40] can also contribute
to this mechanism.
5. Modulation of GABAergic Inhibitory Synapse
The modulation of GABAergic system by P2X receptors was
first observed by the action of presynaptic P2X receptors
located on GABAergic terminals in the retina, spinal cord,
or in midbrain where they regulate the release of GABA
[50, 84, 85]. Direct modulation by postsynaptic P2X recep-
tors of GABAergic inhibitory synaptic transmission was first
identified in the ventromedial nucleus of the hypothalamus
[60, 86]. Blocking the constitutive endocytosis of P2X4 recep-
tors expressed in steroidogenic factor 1 (SF-1) positive neu-
rons increased responses evoked by exogenous application
of ATP but did not reveal fast ATP synaptic transmission.
However, blocking P2X4 endocytosis depressed inhibitory
GABA-mediated postsynaptic currents and consequently
enhanced neuronal excitability of SF-1 neurons. GABA cur-
rent inhibition was independent of ion flow through the
P2X receptors and dependent on a direct interaction between
P2X4 and GABAARs [60]. In addition, disruption of the
physical coupling between P2X4 and GABAA receptors using
competitive peptides corresponding to the interaction
domain identified in the C-terminal tail of P2X4 abolished
P2X4 receptor-mediated GABAergic depression in SF-1
GFP-positive neurons. Molecular and functional cross-
inhibition was also observed between P2X2 or P2X3 and nic-
otinic, GABAA and 5-HT3 receptors in different native or
recombinant cells [87–93]. Therefore, we should consider
the possibility that P2X receptors, although almost silent dur-
ing fast transmission, may be activated by ambient ATP and
exert direct action on various other neurotransmitter recep-
tors at central synapses (Figure 1).
Indeed, a recent study demonstrated that ATP released
from cortical astrocytes modulated phasic and tonic
GABAergic inhibition [28]. In this case, the downregulation
of GABAAR was mediated by the calcium entry through the
opening of P2X receptors. The downregulation of both
tonic and phasic GABAergic transmission relied on the
phosphorylation by PKC and was significantly reduced in
the P2X4 KO and dnSNARE mice. Since phasic and tonic
GABA conductances can influence membrane depolariza-
tion, one may expect that the downregulation of GABA
receptors by astrocyte-derived ATP can be implicated in
the glial modulation of the long-term potentiation. Indeed,
glial exocytosis of ATP has been recently reported to facil-
itate the induction of LTP in neocortical neurons [33, 94].
This effect is dependent on the activity of P2X receptors
[33, 94] and can be mimicked by attenuation of GABAergic
inhibition by GABAAR antagonists [33]. Most likely, P2X-
mediated attenuation of GABAergic inhibition facilitates
LTP induction via increasing the depolarization of postsyn-
aptic neurons and, therefore, alleviating the Mg2+ block of
NMDA receptors (Figure 1).
6. Concluding Remarks
In the ongoing debate on physiological significance of puri-
nergic gliotransmission, the leading role is usually assigned
to adenosine receptors which can modulate synaptic trans-
mission and plasticity via presynaptic and postsynaptic
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mechanisms [2, 3, 20, 21, 26, 95]. In the context of glia-
neuron communications, ATP is often considered merely as
a precursor of adenosine [3, 20, 26, 96]. However, the recent
data discussed in this review highlighted new roles for ATP as
a gliotransmitter and importance of P2X receptors for the
modulation of synaptic transmission at postsynaptic sites.
Furthermore, some of these data have revealed the dynamic
cooperation between synaptic and glial release of ATP in
the regulation of synaptic strength. Importantly, ATP
released from astrocytes can facilitate a recruitment of P2X
receptors into excitatory synapses by Ca2+-dependent mech-
anism [32] thereby acting upstream of synaptic purinergic
signaling. This may underlie a particular physiological rele-
vance of glial release of ATP.
Taken together, the recent data obtained (by different
groups) in the different brain regions and physiological/path-
ological context suggest the existence of complex pathways of
glia-derived purinergic regulation of synaptic transmission at
postsynaptic loci. These pathways, which include the bidirec-
tional modulation of AMPAR-mediated synaptic transmis-
sion, inactivation of NMDAR, and downregulation of
GABAergic inhibition, rely on different intracellular signal-
ing cascades. So, the prevalence of one or another pathway
will be affected by the level expression of specific proteins
(i.e., P2X of different subtypes, PKC, PI3K, CaMKII, and cal-
cineurin) in the particular neuron of particular brain region.
At the same time, the release of ATP from astrocytes can be
activated virtually by any source of cytosolic Ca2+ elevation
[28, 30, 32, 33, 40], which reaches certain threshold. Hence,
the purinergic gliotransmission may have a different out-
come on synaptic plasticity (potentiation versus depres-
sion) depending on the physiological context and activity
of local networks.
There is growing recognition of the importance of
neuronal-glial networks for coordination of metabolism
and information processing in the brain, both in health and
disease [20, 26, 96–98]. The capability of purinoreceptors,
activated by glia-derived ATP, to trigger various Ca2+-depen-
dent intracellular cascades, can make them very important
for such coordination. As discussed above, purinergic astro-
glial modulation of synaptic transmission has many peculiar
features, such as slower time-scale, the dependence on the
activity of surrounding synapses, and ability to change the
balance between excitatory and inhibitory synaptic inputs.
These features can underlie an importance of astroglial
release of ATP for heterosynaptic metaplasticity [96].
One could argue that coordination of activity over large
astroglia syncytium might compromise the synapse specific-
ity of glia-neuron communication, and therefore, the modu-
latory action of gliotransmitters, in particular ATP, would
lack a selectivity needed for Hebbian plasticity. However,
synaptic plasticity and memory require cooperation between
many cellular and molecular mechanisms within neuronal
ensembles, in particular for storage and retrieval of memory
[99, 100]. There is growing consensus that memory and
learning rely on distributed spatial and temporal representa-
tions of events overlaid in a distributed manner within a
common neuronal circuit [100]. So, it is possible that
glia-derived “preconditioning” of excitatory and inhibitory
synapses within neuronal ensemble, for example, via P2X
receptor-linked mechanisms discussed above, can affect
the possibility of associations between stimuli/events. Also,
there is emerging evidence supporting the physiological
importance of fast local Ca2+ events in the astrocytic
microdomains [101]. Potentially, astrocytes are capable of
localized interaction with individual synapses. The ability
of hippocampal and cortical astrocytes to generate Ca2+
elevations in response to activation of single synapse or
single axon has been reported [32, 102]. The activity of
astrocytes can also be input-specific [103]. Thus, it is conceiv-
able that local Ca2+ transients in tiny astrocytic processes can
trigger spatially constrained release of gliotransmitters, for
example, ATP, and selectively affect the activity of an individ-
ual synapse. A putative physiological implication of such
local glia-neuron communications is yet to be investigated.
Interestingly, several works have shown that astroglial
α1-adrenoreceptors can efficiently activate the release of
ATP from astrocytes. Recent data have implicated the adren-
ergic signaling in responsiveness of astrocyte networks to the
behavioural state and sensory inputs [75, 76]. On the other
hand, adrenergic neurons of locus coeruleus, the main source
of noradrenaline release in the brain cortex, can undergo
massive loss during neurodegenerative diseases [104]. Also,
the release of ATP from astrocytes, including the one trig-
gered by α1-adrenoreceptors, can decline with ageing [39].
Thus, astroglial release of ATP by astrocytes as well as by
microglia and purinergic modulation of synaptic transmis-
sion may be of particular importance for the brain metaplas-
ticity induced by experience, environmental factors, ageing,
or neurodegenerative disease [6, 96, 105]. Conversely, mas-
sive release of ATP occurs also from damaged or dying cells
after brain ischemia or trauma or during neurodegenerative
diseases [1, 10, 38, 98] and is often correlated to increased
expression of P2X receptors [1]. Exacerbating ATP P2X sig-
naling may also have profound effect on brain synaptic activ-
ity or plasticity. These very interesting and timely topics are
yet to be explored.
To conclude, recent results strongly support the physio-
logical importance of P2X receptors and astroglial release of
ATP. The purinoreceptor-mediated communication between
astrocytes and neurons is essential for the regulation of
synaptic strength and the modulation of synaptic plasticity.
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